Literature DB >> 28340473

Enantiomers of triclabendazole sulfoxide: Analytical and semipreparative HPLC separation, absolute configuration assignment, and transformation into sodium salt.

Rosella Ferretti1, Simone Carradori2, Paolo Guglielmi3, Marco Pierini3, Adriano Casulli4, Roberto Cirilli5.   

Abstract

Direct HPLC separation of the enantiomers of triclabendazole sulfoxide (TCBZ-SO), which is the main metabolite of the anthelmintic drug triclabendazole, was carried out using the polysaccharide-based Chiralpak AS-H and Chiralpak IF-3 chiral stationary phases (CSPs). The chromatographic behaviour of both CSPs was evaluated and compared using normal-phase and reversed-phase eluents at different column temperatures. The eluent mixture of n-hexane-2-propanol-trifluoroacetic acid 70:30:0.1 (v/v/v) and a column temperature of 40°C were identified as the best operational conditions to carry out semipreparative enantioseparations on a 1-cm I.D. AS-H column. Under these conditions, 12.5mg of racemic sample were resolved in a single chromatographic run within 15min. Comparison of calculated and experimental chiroptical properties provided the absolute configuration assignment at the sulfur atom. The salification of the isolated enantiomers of TCBZ-SO by reaction with sodium hydroxide solution produced water-soluble Na salts which are potentially useful in the development of new anthelmintic enantiomerically pure formulations.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Absolute configuration assignment; Chiralpak AS-H; Chiralpak IF-3; Enantiomers; Parasites; Triclabendazole sulfoxide

Mesh:

Substances:

Year:  2017        PMID: 28340473     DOI: 10.1016/j.jpba.2017.03.021

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.

Authors:  Mar Siles-Lucas; Adriano Casulli; Roberto Cirilli; David Carmena
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

2.  Shortage of Albendazole and Its Consequences for Patients with Cystic Echinococcosis Treated at a Referral Center in Italy.

Authors:  Tommaso Manciulli; Ambra Vola; Mara Mariconti; Raffaella Lissandrin; Marcello Maestri; Christine M Budke; Francesca Tamarozzi; Enrico Brunetti
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

3.  Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold.

Authors:  Giulia Rotondi; Paolo Guglielmi; Simone Carradori; Daniela Secci; Celeste De Monte; Barbara De Filippis; Cristina Maccallini; Rosa Amoroso; Roberto Cirilli; Atilla Akdemir; Andrea Angeli; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

4.  Enantioseparation, Stereochemical Assignment and Chiral Recognition Mechanism of Sulfoxide-Containing Drugs.

Authors:  Fei Xiong; Bei-Bei Yang; Jie Zhang; Li Li
Journal:  Molecules       Date:  2018-10-18       Impact factor: 4.411

5.  Comparison of Coated and Immobilized Chiral Stationary Phases Based on Amylose tris-[(S)-α-Methylbenzylcarbamate] for the HPLC Enantiomer Separation of α-Lipoic Acid and Its Reduced Form.

Authors:  Alessia Rosetti; Claudio Villani; Marco Pierini; Roberto Cirilli
Journal:  Molecules       Date:  2021-03-20       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.